Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Pharvaris N.V.

NASDAQ: PHVS · Life Sciences · 10 alerts · CIK 1830487

Share price
$32.44Close, Nov 16
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Pharvaris N.V. filings on SEC EDGAR ↗

10:43 AM ET Form 4
Insider Selling

Pharvaris Director Johannes Gerardus Christiaan Petrus Schikan Sells $29K of Stock

Johannes Gerardus Christiaan Petrus Schikan, Director, sold 800 shares of Pharvaris N.V. at $36.19 a share, worth $29K in total on Sep 22, 2026. Shares held after the trade: 115,167 (-0.7%).

Value
$29K
Shares
800
Price
$36.19
Role
Director
Holding change
-0.7%
Trade date
Sep 22, 2026
10:06 AM ET Form 4
Insider Selling

Pharvaris CFO / CLO David W. Nassif Sells $219K of Stock

David W. Nassif, CFO / CLO, sold 6,000 shares of Pharvaris N.V. at $36.47 a share, worth $219K in total on Sep 21, 2026. Shares held after the trade: 114,300 (-5.0%).

Value
$219K
Shares
6,000
Price
$36.47
Role
CFO / CLO
Holding change
-5.0%
Trade date
Sep 21, 2026
4:23 PM ET Form 4
Insider Selling

Pharvaris President Peng Lu Sells $3.5M of Stock

Peng Lu, President, sold 100,000 shares of Pharvaris N.V. at $35.00 a share, worth $3.5M in total on Sep 17, 2026. Shares held after the trade: 64,953 (-60.6%).

Value
$3.5M
Shares
100,000
Price
$35.00
Role
President
Holding change
-60.6%
Trade date
Sep 17, 2026
4:19 PM ET Form 4
Insider Selling

Pharvaris Director Johannes Gerardus Christiaan Petrus Schikan Sells $7M of Stock

Johannes Gerardus Christiaan Petrus Schikan, Director, sold 200,000 shares of Pharvaris N.V. at $35.00 a share, worth $7M in total on Sep 17, 2026. Shares held after the trade: 115,167 (-63.5%).

Value
$7M
Shares
200,000
Price
$35.00
Role
Director
Holding change
-63.5%
Trade date
Sep 17, 2026
3:21 PM ET Form 4
Insider Selling

Pharvaris Director Elisabeth Bjork Sells $1.99M of Stock

Elisabeth Bjork, Director, sold 52,500 shares of Pharvaris N.V. at $37.89 a share, worth $1.99M in total on Sep 17, 2026. Shares held after the trade: 15,167 (-77.6%).

Value
$1.99M
Shares
52,500
Price
$37.89
Role
Director
Holding change
-77.6%
Trade date
Sep 17, 2026
3:17 PM ET Form 4
Insider Selling

Pharvaris Director Robert Glassman Sells $559K of Stock

Robert Glassman, Director, sold 14,493 shares of Pharvaris N.V. at $38.56 a share, worth $559K in total on Sep 17, 2026. Shares held after the trade: 10,500 (-58.0%).

Value
$559K
Shares
14,493
Price
$38.56
Role
Director
Holding change
-58.0%
Trade date
Sep 17, 2026
3:14 PM ET Form 4
Insider Selling

Pharvaris Chief Early Development Anne Lesage Sells $765K of Stock

Anne Lesage, Chief Early Development, sold 20,000 shares of Pharvaris N.V. at $38.27 a share, worth $765K in total on Sep 17, 2026. Shares held after the trade: 73,969 (-21.3%).

Value
$765K
Shares
20,000
Price
$38.27
Role
Chief Early Development
Holding change
-21.3%
Trade date
Sep 17, 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.